Edition:
United Kingdom

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

3.46USD
17 Dec 2018
Change (% chg)

-- (--)
Prev Close
$3.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
232,959
52-wk High
$10.54
52-wk Low
$3.09

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: --
Market Cap(Mil.): $220.52
Shares Outstanding(Mil.): 31.75
Dividend: --
Yield (%): --

Financials

  MRNS.OQ Industry Sector
P/E (TTM): -- 31.13 34.40
EPS (TTM): -1.11 -- --
ROI: -85.78 15.55 14.96
ROE: -92.43 16.92 16.53

Earnings vs. Estimates